CompletedPhase 2NCT02804750

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Studying OBSOLETE: Cushing syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Corcept Therapeutics
Principal Investigator
Andreas G Moraitis, MD
Corcept Therapeutics
Intervention
CORT125134(drug)
Enrollment
35 enrolled
Eligibility
18-80 years · All sexes
Timeline
20162018

Study locations (25)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02804750 on ClinicalTrials.gov

Other trials for OBSOLETE: Cushing syndrome

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Cushing syndrome

← Back to all trials